Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
LFE Research Group, Department of Health and Human Performance, Faculty of Physical Activity and Sport Sciences, Universidad Politécnica de Madrid, Madrid, Spain.
Am J Hematol. 2022 Dec;97(12):1548-1559. doi: 10.1002/ajh.26716. Epub 2022 Sep 26.
Systemic iron homeostasis is regulated by the hepatic hormone hepcidin to balance meeting iron requirements while limiting toxicity from iron excess. Iron-mediated induction of bone morphogenetic protein (BMP) 6 is a central mechanism for regulating hepcidin production. Liver endothelial cells (LECs) are the main source of endogenous BMP6, but how they sense iron to modulate BMP6 transcription and thereby hepcidin is uncertain. Here, we investigate the role of endothelial cell transferrin receptor 1 (TFR1) in iron uptake, BMP6 regulation, and systemic iron homeostasis using primary LEC cultures and endothelial Tfrc (encoding TFR1) knockout mice. We show that intracellular iron regulates Bmp6 expression in a cell-autonomous manner, and TFR1 mediates iron uptake and Bmp6 expression by holo-transferrin in primary LEC cultures. In addition, endothelial Tfrc knockout mice exhibit altered iron homeostasis compared with littermate controls when fed a limited iron diet, as evidenced by increased liver iron and inappropriately low Bmp6 and hepcidin expression relative to liver iron. However, endothelial Tfrc knockout mice have a similar iron phenotype compared to littermate controls when fed an iron-rich standard diet. Finally, ferritin and non-transferrin bound iron (NTBI) are additional sources of iron that mediate Bmp6 induction in primary LEC cultures via TFR1-independent mechanisms. Together, our data demonstrate a minor functional role for endothelial cell TFR1 in iron uptake, BMP6 regulation, and hepatocyte hepcidin regulation under iron limiting conditions, and suggest that ferritin and/or NTBI uptake by other transporters have a dominant role when iron availability is high.
系统性铁稳态由肝脏激素铁调素调节,以平衡满足铁需求与限制铁过量的毒性。铁介导的骨形态发生蛋白(BMP)6 的诱导是调节铁调素产生的核心机制。肝内皮细胞(LEC)是内源性 BMP6 的主要来源,但它们如何感知铁来调节 BMP6 转录从而调节铁调素尚不清楚。在这里,我们使用原代 LEC 培养物和内皮 Tfrc(编码 TFR1)敲除小鼠研究了内皮细胞转铁蛋白受体 1(TFR1)在铁摄取、BMP6 调节和全身铁稳态中的作用。我们表明,细胞内铁以细胞自主的方式调节 Bmp6 的表达,TFR1 介导原代 LEC 培养物中全转铁蛋白的铁摄取和 Bmp6 表达。此外,与同窝对照相比,当喂食有限铁饮食时,内皮 Tfrc 敲除小鼠表现出改变的铁稳态,表现为肝脏铁增加,而相对肝脏铁,Bmp6 和铁调素表达不当降低。然而,与同窝对照相比,内皮 Tfrc 敲除小鼠在喂食富含铁的标准饮食时具有相似的铁表型。最后,铁蛋白和非转铁蛋白结合铁(NTBI)是铁调素诱导的其他铁源,通过 TFR1 非依赖性机制在原代 LEC 培养物中发挥作用。总之,我们的数据表明内皮细胞 TFR1 在铁限制条件下铁摄取、BMP6 调节和肝细胞铁调素调节中具有次要的功能作用,并表明铁蛋白和/或 NTBI 摄取由其他转运蛋白在铁可用性高时起主导作用。